Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Social consequences of antiretroviral therapy: preparing for the unexpected futures of HIV-positive children.

Domek GJ.

Lancet. 2006 Apr 22;367(9519):1367-9. No abstract available.

PMID:
16631916
2.

Challenges faced by elderly guardians in sustaining the adherence to antiretroviral therapy in HIV-infected children in Zimbabwe.

Skovdal M, Campbell C, Madanhire C, Nyamukapa C, Gregson S.

AIDS Care. 2011 Aug;23(8):957-64. doi: 10.1080/09540121.2010.542298.

3.

Positive futures: a qualitative study on the needs of adolescents on antiretroviral therapy in South Africa.

Li RJ, Jaspan HB, O'Brien V, Rabie H, Cotton MF, Nattrass N.

AIDS Care. 2010 Jun;22(6):751-8. doi: 10.1080/09540120903431363.

PMID:
20467942
4.

Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa.

Kaida A, Bangsberg DR, Gray G, Hogg RS, King R, Miller CL.

AIDS Behav. 2009 Jun;13 Suppl 1:1-4. doi: 10.1007/s10461-009-9568-4. Epub 2009 May 12. No abstract available.

5.

Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru.

Shin S, Muñoz M, Espiritu B, Zeladita J, Sanchez E, Callacna M, Rojas C, Arevalo J, Wu Y, Caldas A, Sebastian JL.

J Int Assoc Physicians AIDS Care (Chic). 2008 Mar-Apr;7(2):74-81. doi: 10.1177/1545109708315326. Epub 2008 Mar 4.

PMID:
18319510
6.

A one year Greenlandic study of temporary and permanent placement of children and adolescents outside their homes.

Kreutzmann G.

Arctic Med Res. 1995;54 Suppl 1:68-73. No abstract available.

PMID:
7639906
7.

Consequences of HIV for children: avoidable or inevitable?

Desmond C.

AIDS Care. 2009;21 Suppl 1:98-104. doi: 10.1080/09540120903033037. Review.

8.

Adherence without access to antiretroviral therapy in sub-Saharan Africa?

Bangsberg DR, Ware N, Simoni JM.

AIDS. 2006 Jan 2;20(1):140-1; author reply 141-2. No abstract available.

PMID:
16327340
9.

Test of time: children who wait (1973) by Jane Rowe and Lydia Lambert.

Barratt S.

Clin Child Psychol Psychiatry. 2010 Oct;15(4):627-31. doi: 10.1177/1359104510379171. No abstract available.

PMID:
20923908
10.

Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.

Mugglin C, Wandeler G, Estill J, Egger M, Bender N, Davies MA, Keiser O.

PLoS One. 2013;8(2):e56446. doi: 10.1371/journal.pone.0056446. Epub 2013 Feb 20.

11.

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.

Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J.

BMC Pediatr. 2007 Mar 17;7:13.

12.

Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.

Kline MW, Rugina S, Ilie M, Matusa RF, Schweitzer AM, Calles NR, Schwarzwald HL.

Pediatrics. 2007 May;119(5):e1116-20. Epub 2007 Apr 9.

PMID:
17420261
13.

Adherence to highly active antiretroviral therapy and its correlates among HIV infected pediatric patients in Ethiopia.

Biadgilign S, Deribew A, Amberbir A, Deribe K.

BMC Pediatr. 2008 Dec 6;8:53. doi: 10.1186/1471-2431-8-53.

14.

Improving hospital care for young children in the context of HIV/AIDS and poverty.

Richter L, Chandan U, Rochat T.

J Child Health Care. 2009 Sep;13(3):198-211. doi: 10.1177/1367493509336680.

PMID:
19713404
15.

Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.

Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME.

PLoS One. 2011;6(7):e22706. doi: 10.1371/journal.pone.0022706. Epub 2011 Jul 29.

16.

Are the best antiretrovirals being used in Africa?

John L, Kambugu A, Songa PM, Castelnuovo B, Colebunders R, Kamya M.

J HIV Ther. 2006 Mar;11(1):11-5. Review. No abstract available.

PMID:
16706250
17.

Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.

Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, McGibbon CA, Davis SM.

Int J Nurs Stud. 2008 Dec;45(12):1757-63. doi: 10.1016/j.ijnurstu.2008.06.006. Epub 2008 Jul 24.

PMID:
18653188
18.

Paediatric antiretroviral therapy audit in South London.

Doerholt K, Sharland M, Ball C, DuMont G.

HIV Med. 2002 Jan;3(1):44-8.

19.

Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.

Bobat R, Kindra G, Kiepiela P, Reddy S, Jeena PM, Adhikari M, Coovadia HM.

Pediatr Infect Dis J. 2010 Sep;29(9):890. doi: 10.1097/INF.0b013e3181e5a0fe. No abstract available.

PMID:
20720476
20.

Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).

Kapogiannis BG, Soe MM, Nesheim SR, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.

Pediatrics. 2008 May;121(5):e1229-39. doi: 10.1542/peds.2007-0871.

PMID:
18450865
Items per page

Supplemental Content

Write to the Help Desk